サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1490326

ゲノム編集技術市場：2024-2034年

Genome Editing Technologies Market Report 2024-2034
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 311 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=202.15円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ゲノム編集技術市場：2024-2034年
出版日: 2024年05月31日
発行: Visiongain Reports Ltd.
ページ情報: 英文 311 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集技術の市場規模は、2034年にかけてCAGR 17.6％で成長すると予測されています。

業界の成長を後押しする新興経済国：

中国、インド、南アフリカ、メキシコ、シンガポール、ブラジル、ロシア、韓国、インドネシア、トルコなどの新興国は、ゲノム編集技術業界における重要国となりつつあります。特に中国は、ゲノム編集に大規模な投資を行い、同国を世界の研究と応用の最前線に押し上げました。BGI GenomicsやHuada Genomics Instituteなどの機関はCRISPR-Cas9技術の取り組みをリードし、ヒトの健康や農業における飛躍的進歩を達成しています。これらの進歩は、食糧安全保障や持続可能性といった重要な問題に対処するものであり、中国市場におけるライフサイエンス研究の長期的な成長機会となっています。同国のR&D費は2023年に4,585億米ドルを超え、前年比8.1%増となりましたが、これは高齢化による健康需要の高まりを反映しています。

インドとブラジルもゲノム編集技術で顕著な進歩を遂げています。膨大な人口を抱え、バイオテクノロジー分野が急成長しているインドでは、Rasi SeedsやMedGenomeといった企業が作物改良や個別化医療の研究を先導しています。この医療と農業への注力は、社会的利益のためにゲノム編集を活用するというインドのコミットメントを明確に示しています。同様にブラジルは、医療と農業の課題に対処するためのゲノム編集の可能性を認識しています。Embrapaなどの機関やRecepta Biopharmaなどの企業は、国のニーズに合わせた新しい治療法や作物品種を積極的に開発し、精密医療と農業生産性の向上を推進しています。このような取り組みにより、ブラジルは世界のゲノム編集において重要な位置を占めています。

当レポートでは、世界のゲノム編集技術の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 ゲノム編集技術市場の分析：技術別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • CRISPR
  • TALEN
  • ZFN
  • メガヌクレアーゼ
  • その他
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第5章 ゲノム編集技術市場の分析：用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 遺伝子エンジニアリング
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別
    • 細胞株エンジニアリング
    • 動物遺伝子エンジニアリング
    • 植物遺伝子エンジニアリング
    • その他
  • ドラッグディスカバリー・薬剤開発
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別
  • 診断
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第6章 ゲノム編集技術市場の分析：エンドユーザー別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • バイオテクノロジー企業
  • 製薬会社
  • 学術・政府研究機関
  • その他
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第7章 ゲノム編集技術市場の分析：地域別

  • 主要調査結果
  • 市場規模の推移・予測

第8章 北米のゲノム編集技術市場の分析

第9章 欧州のゲノム編集技術市場の分析

第10章 アジアのゲノム編集技術市場の分析

第11章 ラテンアメリカのゲノム編集技術市場の分析

第12章 中東・アフリカのゲノム編集技術市場の分析

第13章 企業プロファイル

  • 競合情勢
  • 戦略的展望
  • Thermo Fisher Scientific Inc.
  • Lonza
  • CRISPR Therapeutics
  • Editas Medicine
  • Revvity
  • Agilent Technologies
  • GenScript
  • Merck KGaA
  • Sangamo Therapeutics
  • Precision Biosciences
  • Tecan Trading AG
  • Takara Bio Inc.
  • Danaher Corporation
  • Recombinetics
  • Intellia Therapeutics Inc.
  • Cellectis
  • Cibus Inc.
  • Caribou Biosciences, Inc.

第14章 総論・提言

  • Visiongainによる総論
  • 市場参入企業への提言
図表

List of Tables

  • Table 1 Genome Editing Technologies Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Worldwide Chronic Diseases Incidence, 2023 (Million)
  • Table 3 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 4 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 5 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 6 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 7 Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 CRISPR Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 TALEN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 ZFN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Meganucleases Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Genetic Engineering Segment Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Cell Line Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Animal Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Plant Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Drug Discovery & Development Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Diagnostic Applications Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Biotechnology companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Pharmaceutical Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 Academic & Government Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 North America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 North America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 North America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 North America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 North America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 U.S. Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Canada Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Europe Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Europe Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Europe Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 Europe Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 Europe Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Germany Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 UK Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 France Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Italy Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 Spain Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 Russia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Rest of Europe Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Asia Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Asia Pacific Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Asia Pacific Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Asia Pacific Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 Asia Pacific Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Japan Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 China Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 India Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Australia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 South Korea Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Rest of Asia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Latin America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Latin America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Latin America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Latin America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Latin America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Brazil Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Mexico Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Argentina Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 Rest of Latin America Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 MEA Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 MEA Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 MEA Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 MEA Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 MEA Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 GCC Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 South Africa Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Rest of MEA Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 Strategic Outlook
  • Table 76 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 78 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 79 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Lonza: Product Benchmarking
  • Table 81 Lonza: Strategic Outlook
  • Table 82 CRISPR Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 CRISPR Therapeutics: Product Benchmarking
  • Table 84 CRISPR Therapeutics: Strategic Outlook
  • Table 85 Editas Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 Editas Medicine: Product Benchmarking
  • Table 87 Editas Medicine: Strategic Outlook
  • Table 88 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Revvity: Product Benchmarking
  • Table 90 Revvity: Strategic Outlook
  • Table 91 Agilent Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Agilent Technologies: Product Benchmarking
  • Table 93 Agilent Technologies: Strategic Outlook
  • Table 94 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 GenScript: Product Benchmarking
  • Table 96 GenScript: Strategic Outlook
  • Table 97 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Merck KGaA: Product Benchmarking
  • Table 99 Merck KGaA: Strategic Outlook
  • Table 100 Sangamo Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Sangamo Therapeutics: Product Benchmarking
  • Table 102 Sangamo Therapeutics: Strategic Outlook
  • Table 103 Precision Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Precision Biosciences: Product Benchmarking
  • Table 105 Precision Biosciences: Strategic Outlook
  • Table 106 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Tecan Trading AG: Product Benchmarking
  • Table 108 Tecan Trading AG: Strategic Outlook
  • Table 109 Takara Bio Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Takara Bio Inc.: Product Benchmarking
  • Table 111 Takara Bio Inc.: Strategic Outlook
  • Table 112 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Danaher Corporation: Product Benchmarking
  • Table 114 Danaher Corporation: Strategic Outlook
  • Table 115 Recombinetics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Recombinetics: Product Benchmarking
  • Table 117 Intellia Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Intellia Therapeutics Inc.: Product Benchmarking
  • Table 119 Intellia Therapeutics Inc.: Strategic Outlook
  • Table 120 Cellectis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Cellectis: Product Benchmarking
  • Table 122 Cellectis: Strategic Outlook
  • Table 123 Cibus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Cibus Inc.: Product Benchmarking
  • Table 125 Cibus Inc.: Strategic Outlook
  • Table 126 Caribou Biosciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Caribou Biosciences, Inc.: Product Benchmarking

List of Figures

  • Figure 1 Genome Editing Technologies Market Segmentation
  • Figure 2 Genome Editing Technologies Market by Technology: Market Attractiveness Index
  • Figure 3 Genome Editing Technologies Market by Application: Market Attractiveness Index
  • Figure 4 Genome Editing Technologies Market by End-users: Market Attractiveness Index
  • Figure 5 Genome Editing Technologies Market Attractiveness Index by Region
  • Figure 6 Genome Editing Technologies Market: Market Dynamics
  • Figure 7 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 8 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 9 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 10 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 11 Genome Editing Technologies Market: Porter's Five Forces Analysis
  • Figure 12 Genome Editing Technologies Market: PEST Analysis
  • Figure 13 Genome Editing Technologies Market by Technology: Market Attractiveness Index
  • Figure 14 Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 15 Genome Editing Technologies Share Forecast by Technology, 2024, 2029, 2034 (%)
  • Figure 16 CRISPR Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 17 CRISPR Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 18 TALEN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 19 TALEN Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 ZFN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 21 ZFN Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Meganucleases Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 23 Meganucleases Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 25 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Genome Editing Technologies Market by Application: Market Attractiveness Index
  • Figure 27 Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Genome Editing Technologies Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 29 Genetic Engineering Segment Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 30 Genetic Engineering Segment Market Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 31 Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 32 Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 33 Cell Line Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 34 Cell Line Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 35 Animal Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 36 Animal Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Plant Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 38 Plant Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Drug Discovery & Development Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 42 Drug Discovery & Development Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Diagnostic Applications Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Diagnostic Applications Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Genome Editing Technologies Market by End-users: Market Attractiveness Index
  • Figure 46 Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 47 Genome Editing Technologies Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 48 Biotechnology companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 49 Biotechnology companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 50 Pharmaceutical Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 51 Pharmaceutical Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 Academic & Government Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 53 Academic & Government Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 55 Other End-users Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Genome Editing Technologies Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 57 Genome Editing Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 58 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 59 North America Genome Editing Technologies Market Attractiveness Index
  • Figure 60 North America Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 61 North America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 62 North America Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 63 North America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 64 North America Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 65 North America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 66 North America Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 67 North America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
  • Figure 68 North America Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
  • Figure 69 North America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 70 North America Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 71 U.S. Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 72 Canada Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 73 Europe Genome Editing Technologies Market Attractiveness Index
  • Figure 74 Europe Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 75 Europe Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 76 Europe Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 77 Europe Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 78 Europe Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 79 Europe Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 80 Europe Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 81 Europe Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
  • Figure 82 Europe Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
  • Figure 83 Europe Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 84 Europe Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 85 Germany Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 86 UK Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 87 France Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 88 Italy Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 89 Spain Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 90 Russia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 91 Rest of Europe Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 92 Asia Genome Editing Technologies Market Attractiveness Index
  • Figure 93 Asia Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 94 Asia Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 95 Asia Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 96 Asia Pacific Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 97 Asia Pacific Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 98 Asia Pacific Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Asia Pacific Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 100 Asia Pacific Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Asia Pacific Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
  • Figure 102 Asia Pacific Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 103 Asia Pacific Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 104 Japan Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 105 China Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 106 India Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 107 Australia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 108 South Korea Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Rest of Asia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 110 Latin America Genome Editing Technologies Market Attractiveness Index
  • Figure 111 Latin America Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 112 Latin America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 113 Latin America Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 114 Latin America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 115 Latin America Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 116 Latin America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 117 Latin America Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 118 Latin America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
  • Figure 119 Latin America Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
  • Figure 120 Latin America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 121 Latin America Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 122 Brazil Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 123 Mexico Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Argentina Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 125 Rest of Latin America Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 126 MEA Genome Editing Technologies Market Attractiveness Index
  • Figure 127 MEA Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 128 MEA Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 129 MEA Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 130 MEA Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 131 MEA Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 132 MEA Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 133 MEA Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 134 MEA Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
  • Figure 135 MEA Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
  • Figure 136 MEA Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 137 MEA Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 138 GCC Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 139 South Africa Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 140 Rest of MEA Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 141 Clinical Trial Supplies Market: Company Share, 2023
  • Figure 142 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 143 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 144 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2023
  • Figure 145 Lonza: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 146 Lonza: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 147 CRISPR Therapeutics: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 148 CRISPR Therapeutics: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 149 Editas Medicine: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 150 Editas Medicine: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 151 Revvity: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 152 Revvity: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 153 Revvity: Regional Market Shares (%), 2023
  • Figure 154 Agilent Technologies: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 155 Agilent Technologies: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 156 Agilent Technologies: Regional Market Shares (%), 2023
  • Figure 157 GenScript: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 158 GenScript: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 159 Merck KGaA: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 160 Merck KGaA: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 161 Merck KGaA: Regional Market Shares (%), 2023
  • Figure 162 Sangamo Therapeutics: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 163 Sangamo Therapeutics: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 164 Precision Biosciences: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 165 Precision Biosciences: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 166 Tecan Trading AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 167 Tecan Trading AG: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 168 Tecan Trading AG: Regional Market Shares (%), 2023
  • Figure 169 Takara Bio Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 170 Danaher Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 171 Danaher Corporation: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 172 Danaher Corporation: Regional Market Shares (%), 2023
  • Figure 173 Intellia Therapeutics Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 174 Intellia Therapeutics Inc.: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 175 Cellectis: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 176 Cellectis: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 177 Cellectis: Regional Market Shares (%), 2023
  • Figure 178 Cibus Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 179 Cibus Inc.: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 180 Caribou Biosciences, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
  • Figure 181 Caribou Biosciences, Inc.: R&D, 2019-2023 (US$ Million, AGR%)
  • Figure 182 Caribou Biosciences, Inc.: Regional Market Shares (%), 2023
目次
Product Code: PHA1339

The global Genome Editing Technologies market is projected to grow at a CAGR of 17.6% by 2034

The Genome Editing Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Emerging Economies Projected to Boost Industry Growth

Emerging economies such as China, India, South Africa, Mexico, Singapore, Brazil, Russia, South Korea, Indonesia, and Turkey are becoming significant players in the genome editing technologies industry. China, in particular, has made substantial investments and advancements in genome editing, propelling the nation to the forefront of global research and application. Institutions like BGI Genomics and Huada Genomics Institute are leading efforts in CRISPR-Cas9 technology, achieving breakthroughs in human health and significant strides in agriculture. These advancements address critical issues such as food security and sustainability, presenting a significant long-term growth opportunity for life science research in the Chinese market. The country's spending on R&D surpassed US$458.5 billion in 2023, an 8.1% increase from the previous year, reflecting rising health demands from an aging population.

India and Brazil are also making notable progress in genome editing technologies. India, with its vast population and burgeoning biotechnology sector, has companies like Rasi Seeds and MedGenome spearheading research in crop improvement and personalized medicine. This focus on healthcare and agriculture highlights India's commitment to leveraging genome editing for societal benefit. Similarly, Brazil is recognizing the potential of genome editing to address its healthcare and agricultural challenges. Institutions like Embrapa and companies like Recepta Biopharma are actively developing novel therapies and crop varieties tailored to the country's needs, driving advancements in precision medicine and agricultural productivity. These efforts position Brazil as a key player in the global genome editing landscape.

Off-target Effects of CRISPR Technology Likely to Challenge Industry Growth

One major limitation of gene editing technology is the off-target effects of CRISPR-Cas9. While CRISPR can target specific genes with high precision, it can also cause unintended alterations at other sites in the genome. These off-target effects present risks and challenges, making it essential to ensure precise targeting to avoid unwanted changes and adverse outcomes. Researchers are improving CRISPR procedures to increase specificity and reduce off-target effects through advancements in guide RNA design, high-fidelity Cas9 variants, and bioinformatics tools.

Off-target effects pose significant concerns for the safety and efficacy of genome editing treatments, impeding market demand. Unintended genetic changes can lead to harmful side effects, potentially introducing new mutations or exacerbating existing conditions. Regulatory scrutiny and public perception further hinder market growth. Regulators, like the FDA, require rigorous testing to ensure safety, which is time-consuming and costly. Public skepticism about the risks of off-target effects can also deter patients from seeking genome editing treatments. To address these challenges, researchers are developing new tools and techniques to enhance CRISPR precision and mitigate off-target effects, aiming to boost confidence and demand in the market.

What Questions Should You Ask before Buying a Market Research Report?

How is the genome editing technologies market evolving?

What is driving and restraining the genome editing technologies market?

How will each genome editing technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each genome editing technologies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading genome editing technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the genome editing technologies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of genome editing technologies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the genome editing technologies market?

Where is the genome editing technologies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the genome editing technologies market today, and over the next 10 years:

Our 311-page report provides 127 tables and 182 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the genome editing technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising genome editing technologies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Technology

CRISPR

TALEN

ZFN

Meganucleases

Others

Application

Genetic Engineering

Cell Line Engineering

Animal Genetic Engineering

Plant Genetic Engineering

Others

Drug Discovery & Development

Diagnostic Applications

End-users

Biotechnology Companies

Pharmaceutical Companies

Academic & Government Research Institutes

Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Genome Editing Technologies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Agilent Technologies

Caribou Biosciences, Inc.

Cellectis

Cibus Inc.

CRISPR Therapeutics

Danaher Corporation

Editas Medicine

GenScript

Intellia Therapeutics Inc.

Lonza

Merck KGaA

Precision Biosciences

Recombinetics

Revvity

Sangamo Therapeutics

Takara Bio Inc.

Tecan Trading AG

Thermo Fisher Scientific Inc.

Overall world revenue for Genome Editing Technologies Market, 2024 to 2034 in terms of value the market will surpass US$6,300.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Genome Editing Technologies Market, 2024 to 2034 report help you?

In summary, our 310+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Genome Editing Technologies Market, 2024 to 2034, with forecasts for technology, application, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Genome Editing Technologies Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 18 of the major companies involved in the Genome Editing Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Genome Editing Technologies Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Genome Editing Technologies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Number of Genomic Projects Coupled with the Government Funding
      • 3.2.1.2 Rising Adoption of Genome Editing Technologies
      • 3.2.1.3 Rising Burden of Chronic Diseases
      • 3.2.1.4 Increasing Applications of Genomics for Medicine, Agriculture, and Biotechnology
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Off-target Effects of CRISPR Technology
      • 3.2.2.2 High Cost of Genome Editing Technologies
      • 3.2.2.3 Regulatory Hurdles for Genome Editing Technology Application
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Rising Demand for Genome Editing Technology in Emerging Economies
      • 3.2.3.2 Strong Product Pipeline with Genome Editing Technology
      • 3.2.3.3 Collaboration and Partnerships among Genome Editing Technologies Companies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Genome Editing Technologies Market Analysis by Technology

  • 4.1 Key Findings
  • 4.2 Technology Segment: Market Attractiveness Index
  • 4.3 Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 4.4 CRISPR
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 TALEN
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 ZFN
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Meganucleases
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Others
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)

5 Genome Editing Technologies Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Genome Editing Technologies Market Size Estimation and Forecast by Application
  • 5.4 Genetic Engineering
    • 5.4.1 Market Size Estimation and Forecast by Type
    • 5.4.2 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.3 Market Share by Region, 2024 & 2034 (%)
    • 5.4.4 Cell Line Engineering
      • 5.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.5 Animal Genetic Engineering
      • 5.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.6 Plant Genetic Engineering
      • 5.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.6.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.7 Others
      • 5.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Drug Discovery & Development
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Diagnostic Applications
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Genome Editing Technologies Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 6.4 Biotechnology Companies
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Pharmaceutical Companies
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Academic & Government Research Institutes
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Other End-users
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Genome Editing Technologies Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Genome Editing Technologies Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Genome Editing Technologies Market Attractiveness Index
  • 8.3 North America Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 8.4 North America Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 8.5 North America Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 8.6 North America Genome Editing Technologies Market Size Estimation and Forecast by Application
    • 8.6.1 North America Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
  • 8.7 North America Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 8.8 U.S. Genome Editing Technologies Market Analysis
  • 8.9 Canada Genome Editing Technologies Market Analysis

9 Europe Genome Editing Technologies Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Genome Editing Technologies Market Attractiveness Index
  • 9.3 Europe Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 9.4 Europe Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 9.5 Europe Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 9.6 Europe Genome Editing Technologies Market Size Estimation and Forecast by Application
    • 9.6.1 Europe Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
  • 9.7 Europe Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 9.8 Germany Genome Editing Technologies Market Analysis
  • 9.9 UK Genome Editing Technologies Market Analysis
  • 9.10 France Genome Editing Technologies Market Analysis
  • 9.11 Italy Genome Editing Technologies Market Analysis
  • 9.12 Spain Genome Editing Technologies Market Analysis
  • 9.13 Russia Genome Editing Technologies Market Analysis
  • 9.14 Rest of Europe Genome Editing Technologies Market Analysis

10 Asia Genome Editing Technologies Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Genome Editing Technologies Market Attractiveness Index
  • 10.3 Asia Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 Asia Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 10.6 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Application
    • 10.6.1 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
  • 10.7 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 10.8 Japan Genome Editing Technologies Market Analysis
  • 10.9 China Genome Editing Technologies Market Analysis
  • 10.10 India Genome Editing Technologies Market Analysis
  • 10.11 Australia Genome Editing Technologies Market Analysis
  • 10.12 South Korea Genome Editing Technologies Market Analysis
  • 10.13 Rest of Asia Genome Editing Technologies Market Analysis

11 Latin America Genome Editing Technologies Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Genome Editing Technologies Market Attractiveness Index
  • 11.3 Latin America Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 11.5 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 11.6 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Application
    • 11.6.1 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
  • 11.7 Latin America Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 11.8 Brazil Genome Editing Technologies Market Analysis
  • 11.9 Mexico Genome Editing Technologies Market Analysis
  • 11.10 Argentina Genome Editing Technologies Market Analysis
  • 11.11 Rest of Latin America Genome Editing Technologies Market Analysis

12 MEA Genome Editing Technologies Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Genome Editing Technologies Market Attractiveness Index
  • 12.3 MEA Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 MEA Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 12.5 MEA Genome Editing Technologies Market Size Estimation and Forecast by Technology
  • 12.6 MEA Genome Editing Technologies Market Size Estimation and Forecast by Application
    • 12.6.1 MEA Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
  • 12.7 MEA Genome Editing Technologies Market Size Estimation and Forecast by End-users
  • 12.8 GCC Genome Editing Technologies Market Analysis
  • 12.9 South Africa Genome Editing Technologies Market Analysis
  • 12.10 Rest of MEA Genome Editing Technologies Market Analysis

13 Company Profiles

  • 13.1 Competitive Landscape, 2023
  • 13.2 Strategic Outlook
  • 13.3 Thermo Fisher Scientific Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2018-2023
      • 13.3.3.2 R&D, 2018-2023
      • 13.3.3.3 Regional Market Shares, 2023
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Lonza
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2018-2023
      • 13.4.3.2 R&D, 2018-2023
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 CRISPR Therapeutics
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2018-2023
      • 13.5.3.2 R&D, 2018-2023
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Editas Medicine
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2018-2023
      • 13.6.3.2 R&D, 2018-2023
    • 13.6.4 Product Benchmarking
    • 13.6.5 Strategic Outlook
  • 13.7 Revvity
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2018-2023
      • 13.7.3.2 R&D, 2018-2023
      • 13.7.3.3 Regional Market Shares, 2023
    • 13.7.4 Product Benchmarking
    • 13.7.5 Strategic Outlook
  • 13.8 Agilent Technologies
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2018-2023
      • 13.8.3.2 R&D, 2018-2023
      • 13.8.3.3 Regional Market Shares, 2023
    • 13.8.4 Product Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 GenScript
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2018-2023
      • 13.9.3.2 R&D, 2018-2023
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 Merck KGaA
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
      • 13.10.3.1 Net Revenue, 2018-2023
      • 13.10.3.2 R&D, 2018-2023
      • 13.10.3.3 Regional Market Shares, 2023
    • 13.10.4 Product Benchmarking
    • 13.10.5 Strategic Outlook
  • 13.11 Sangamo Therapeutics
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2018-2023
      • 13.11.3.2 R&D, 2018-2023
    • 13.11.4 Product Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 Precision Biosciences
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2018-2023
      • 13.12.3.2 R&D, 2018-2023
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook
  • 13.13 Tecan Trading AG
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Net Revenue, 2018-2023
      • 13.13.3.2 R&D, 2018-2023
      • 13.13.3.3 Regional Market Shares, 2023
    • 13.13.4 Product Benchmarking
    • 13.13.5 Strategic Outlook
  • 13.14 Takara Bio Inc.
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2018-2023
    • 13.14.4 Product Benchmarking
    • 13.14.5 Strategic Outlook
  • 13.15 Danaher Corporation
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis
      • 13.15.3.1 Net Revenue, 2018-2023
      • 13.15.3.2 R&D, 2018-2023
      • 13.15.3.3 Regional Market Shares, 2023
    • 13.15.4 Product Benchmarking
    • 13.15.5 Strategic Outlook
  • 13.16 Recombinetics
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Product Benchmarking
  • 13.17 Intellia Therapeutics Inc.
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Financial Analysis
      • 13.17.3.1 Net Revenue, 2018-2023
      • 13.17.3.2 R&D, 2018-2023
    • 13.17.4 Product Benchmarking
    • 13.17.5 Strategic Outlook
  • 13.18 Cellectis
    • 13.18.1 Company Snapshot
    • 13.18.2 Company Overview
    • 13.18.3 Financial Analysis
      • 13.18.3.1 Net Revenue, 2018-2023
      • 13.18.3.2 R&D, 2018-2023
      • 13.18.3.3 Regional Market Shares, 2023
    • 13.18.4 Product Benchmarking
    • 13.18.5 Strategic Outlook
  • 13.19 Cibus Inc.
    • 13.19.1 Company Snapshot
    • 13.19.2 Company Overview
    • 13.19.3 Financial Analysis
      • 13.19.3.1 Net Revenue, 2018-2023
      • 13.19.3.2 R&D, 2018-2023
    • 13.19.4 Product Benchmarking
    • 13.19.5 Strategic Outlook
  • 13.20 Caribou Biosciences, Inc.
    • 13.20.1 Company Snapshot
    • 13.20.2 Company Overview
    • 13.20.3 Financial Analysis
      • 13.20.3.1 Net Revenue, 2019-2023
      • 13.20.3.2 R&D, 2019-2023
      • 13.20.3.3 Regional Market Shares, 2023
    • 13.20.4 Product Benchmarking

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players